Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses in HIV Vaccine Trial Participants Who Subsequently Acquire HIV-1 Infection

Candidate human immunodeficiency virus type 1 (HIV-1) vaccines designed to elicit T-cell immunity in HIV-1-uninfected persons are under investigation in phase I to III clinical trials. Little is known about how these vaccines impact the immunologic response postinfection in persons who break through...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Horton, Helen, Havenar-Daughton, Colin, Lee, Deborah, Moore, Erin, Cao, Jianhong, McNevin, John, Andrus, Thomas, Zhu, Haiying, Rubin, Abbe, Zhu, Tuofu, Celum, Connie, McElrath, M. Juliana
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society for Microbiology 2006
الموضوعات:
Vaccines and Antiviral Agents
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC1617262/
https://ncbi.nlm.nih.gov/pubmed/16973582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00794-06
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة